Article Details
Retrieved on: 2019-04-06 18:48:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>BlackRock Inc</b>. raised its position in Akebia Therapeutics Inc (NASDAQ:AKBA) by 57.5% during the 4th quarter, according to its most recent filing with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here